Chemokines and Their Receptors: Potential Therapeutic Targets for Bone Cancer Pain

E-ISSN： 1873-4286|21|34|5029-5033

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.34, 2015-10, pp. : 5029-5033

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-01 ,pp. : 279-290

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokines as Potential Therapeutic Targets in Atherosclerosis

Current Drug Targets, Vol. 7, Iss. 1, 2006-01 ,pp. : 13-27

Bentham Science Publishers

Access to resources Recommend Favorite

GABAB Receptors as Potential Therapeutic Targets

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 4, 2003-08 ,pp. : 248-259

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokines and their Receptors as Therapeutic Targets: The Role of the SDF-1 / CXCR4 Axis

Current Pharmaceutical Design, Vol. 10, Iss. 11, 2004-04 ,pp. : 1245-1259

Bentham Science Publishers

Access to resources Recommend Favorite

Bone Morphogenetic Proteins and its Receptors; Therapeutic Targets in Cancer Progression and Bone Metastasis?

Current Pharmaceutical Design, Vol. 16, Iss. 11, 2010-04 ,pp. : 1291-1300

Bentham Science Publishers

Access to resources Recommend Favorite